Enhancement of myeloma development mediated though myeloma cell-Th2 cell interactions after microbial antigen

Blood Cancer Journal
|July 26, 2012
PubMed

Insights

Microbes and microbial antigens can directly impact myeloma progression. Bacillus Calmette-Guerin Vaccine-specific Th2 cells promote myeloma growth by upregulating HLA-DR and CD40, suggesting new therapeutic targets.

Area of Science:

  • Immunology
  • Oncology
  • Microbiology

Background:

  • Microbial agents are potential carcinogens, but their direct role in myeloma tumor biology is unclear.
  • Previous research has not established a direct link between Th2 cells and myeloma growth promotion.

Purpose of the Study:

  • To investigate the direct effects of microbial antigens and microbial-specific T helper 2 (Th2) cells on myeloma cells.
  • To explore the mechanisms by which microbial factors influence myeloma progression and identify potential therapeutic targets.

Main Methods:

  • Upregulation of HLA-DR and CD40 on myeloma cells by interferon-γ and microbial antigens.
  • Stimulation of Bacillus Calmette-Guerin Vaccine (BCGV)-specific Th2 cells using BCGV-loaded dendritic cells (DCs).
  • Assessment of myeloma clonogenicity, B-cell lymphoma 6 (Bcl-6) protein expression, and cell surface marker proportions in Th2 cell-stimulated myeloma cells.

Main Results:

  • BCGV-specific Th2 cells directly promoted myeloma clonogenicity in MHC-II(+) myeloma cells that took up BCGV antigen.
  • Th2 cell stimulation led to increased Bcl-6 protein expression and a higher proportion of HLA-DR(+) or CD40(+) myeloma cells.
  • Blocking HLA-DR or CD40 with antibodies inhibited the increase in Bcl-6 expression and colony number.

Conclusions:

  • Microbes and microbial antigen-specific Th2 cells can directly influence myeloma biology and promote tumor progression.
  • Activation appears specific to MHC-II(+) myeloma cells with B cell and stem cell characteristics.
  • Dendritic cells and Th2 cells involved in microbial antigen presentation are potential targets for myeloma therapy.

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...